NeuroSense Therapeutics
NRSN
NRSN
8 hedge funds and large institutions have $304K invested in NeuroSense Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
$129K |
2 |
WP
Woodline Partners
San Francisco,
California
|
$35.6K |
3 |
UBS Group
Zurich,
Switzerland
|
$21.7K |
Top Sellers
1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
$91K |
2 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
$0 |
3 |
HF
HRT Financial
New York
|
$0 |
4 |
Morgan Stanley
New York
|
$2.73K |